His primary areas of study are Epitope, Virology, Immunology, Human leukocyte antigen and Major histocompatibility complex. He interconnects T cell, CD8 and Immune system in the investigation of issues within Epitope. His study on Virus is often connected to Context as part of broader study in Virology.
His work focuses on many connections between Immunology and other disciplines, such as Cytotoxic T cell, that overlap with his field of interest in Dengue virus, Parkinson's disease and Alpha-synuclein. His work on HLA-B as part of his general Human leukocyte antigen study is frequently connected to Population, thereby bridging the divide between different branches of science. His work in the fields of Peptide binding overlaps with other areas such as Repertoire.
His scientific interests lie mostly in Epitope, Virology, Immunology, T cell and Human leukocyte antigen. The concepts of his Epitope study are interwoven with issues in MHC class I, Major histocompatibility complex, CD8 and Immune system. His work is dedicated to discovering how Major histocompatibility complex, Computational biology are connected with Immune Epitope Database and Analysis Resource and other disciplines.
John Sidney has researched Virology in several fields, including Cytotoxic T cell, CTL* and Immunodominance. His T cell research is multidisciplinary, incorporating elements of Molecular biology and Vaccination. In the subject of general Human leukocyte antigen, his work in HLA-A is often linked to Population, thereby combining diverse domains of study.
John Sidney spends much of his time researching Epitope, T cell, Human leukocyte antigen, Virology and Antigen. His work carried out in the field of Epitope brings together such families of science as Cytotoxic T cell and Major histocompatibility complex, CD8, Immune system. John Sidney combines subjects such as Molecular biology, Antibody and Immunotherapy with his study of T cell.
His research integrates issues of Computational biology and Allele in his study of Human leukocyte antigen. His Virology research focuses on Immunity and how it relates to Peptide vaccine. His Antigen research is multidisciplinary, incorporating perspectives in Cancer cell, Proteome and Antigen presentation.
His primary scientific interests are in Epitope, Virology, T cell, Antigen and CD8. The Epitope study combines topics in areas such as Immunogenicity, Human leukocyte antigen, Cytotoxic T cell, Antigen presentation and Computational biology. His Virology study integrates concerns from other disciplines, such as Naive B cell, Antibody and Epitope mapping.
His T cell study is within the categories of Immunology and Immune system. His work in Antigen tackles topics such as Cancer cell which are related to areas like Cell biology, Proteasome, Proteomics, Mutation and Cell culture. The various areas that John Sidney examines in his CD8 study include Molecular biology, Adoptive cell transfer, Glioma and T-cell receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
Peng Wang;John Sidney;Courtney Dow;Courtney Dow;Bianca Mothé.
PLOS Computational Biology (2008)
NetMHCpan, a method for MHC class I binding prediction beyond humans
Ilka Hoof;Bjoern Peters;John Sidney;Lasse Eggers Pedersen.
HLA class I supertypes: a revised and updated classification
John Sidney;Bjoern Peters;Nicole Frahm;Christian Brander.
BMC Immunology (2008)
The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.
Ann L Erickson;Yoichi Kimura;Suzu Igarashi;Jennifer Eichelberger.
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.
Magdalini Moutaftsi;Bjoern Peters;Valerie Pasquetto;David C Tscharke.
Nature Biotechnology (2006)
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Alba Grifoni;John Sidney;Yun Zhang;Richard H. Scheuermann.
Cell Host & Microbe (2020)
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris.
Nature Medicine (1999)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang;John Sidney;Yohan Kim;Alessandro Sette.
BMC Bioinformatics (2010)
The immune epitope database and analysis resource: from vision to blueprint.
Bjoern Peters;John Sidney;Phil Bourne;Huynh-Hoa Bui.
PLOS Biology (2005)
Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov.
Nature Medicine (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: